)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
BiBBInstruments
BiBBInstruments (BIBB) investor relations material
BiBBInstruments Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary6 Nov, 2026
Executive summary
EndoDrill® GI commercialization advanced with a Spanish launch alongside Palex and larger US orders from TaeWoong Medical USA; recurring sales depend on wider hospital adoption and repeat use.
Priorities are expanding US use, building on the Spain launch, securing more European distribution partners, and preparing EndoDrill® EBUS for production and market introduction.
Financial highlights
Q3 2026 net sales were SEK 178K vs SEK 110K; operating result was SEK -4.615M vs SEK -2.846M, and result after financial items was SEK -4.584M vs SEK -2.846M.
9M 2026 net sales were SEK 763K vs SEK 149K; operating result was SEK -15.045M vs SEK -9.599M, and result after financial items was SEK -15.015M vs SEK -9.539M.
Q3 gross result was SEK -39K vs SEK 27K; 9M gross result was SEK 30K vs SEK 46K. Higher R&D costs and lower capitalization of development outlays contributed to the weaker operating result.
Q3 R&D costs were SEK 3.116M vs SEK 1.753M; 9M R&D costs were SEK 9.963M vs SEK 5.675M.
Outlook and guidance
Current cash is expected to fund planned operations through year-end 2027/2028; Q3 average cash burn was approximately SEK 1.8M per month.
EndoDrill® EBUS production is planned to start in the coming months; preparations continue for a European notified-body change notification and a US FDA 510(k) submission.
2026 commercial priorities include increasing EndoDrill® GI use in the US, following up the Spanish launch, and establishing additional European distribution partnerships.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from BiBBInstruments
- First European distribution, record US sales, and strong funding drive expansion.BIBB
Q2 2026 - US launch and financing drive expansion, with strong clinical data and increased R&D spend.BIBBQ1 2026
- Commercial launch in the US, first sales, and strong financial base set stage for 2026 expansion.BIBBQ4 2025
- EndoDrill® GI launched in the US, marking a milestone with first sales and clinical validation.BIBBQ3 2025
- Exclusive US distribution, patent milestones, and strong financials position for 2026 growth.BIBBQ2 2025
- EndoDrill® Gl achieved 100% diagnostic accuracy as BiBB readies for commercial launch.BIBBQ3 2024
- EndoDrill GI clinical rollout advances, funding secured, and global expansion preparations underway.BIBBQ2 2024
- Strong start to 2025 with new funding, first US order, and positive clinical results.BIBBQ1 2025
- EndoDrill® achieved CE-marking, 100% diagnostic accuracy, and its first US order in 2024.BIBBQ4 2024
Next BiBBInstruments earnings date
Q4 202612 Feb, 2027
BiBBInstruments
Next BiBBInstruments earnings date
Q4 202612 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
BiBBInstruments AB is a Sweden-based medical technology company focused on developing diagnostic devices for early cancer detection. The company’s flagship product, EndoDrill, is a series of innovative biopsy instruments designed to improve the precision and effectiveness of tissue sampling in endoscopic procedures. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.